business
Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion
Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion
Read full story on Yahoo Finance → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop